Work

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

Year: 2006

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Osteoporosis International

DOI: 10.1007/s00198-006-0177-z

Authors: M. C. Nevitt, P. Chen, D. P. Kiel, J.-Y. Reginster, R. K. Dore, J. R. Zanchetta, E. V. Glass, J. H. Krege

Institutions: University of California, San Francisco, Eli Lilly (United States), Harvard University, Hebrew SeniorLife, University of Liège, University of California, Los Angeles, Instituto de Diagnóstico e Investigaciones Metabólicas

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2053010770

FWCI: 0.219

Cites: 21

Cited by: 55

Related to: 10